[go: up one dir, main page]

NO970428L - Fremgangsmåte for fremstilling av antimikrobielle kinolonyllaktamforbindelser og nye mellomprodukter - Google Patents

Fremgangsmåte for fremstilling av antimikrobielle kinolonyllaktamforbindelser og nye mellomprodukter

Info

Publication number
NO970428L
NO970428L NO970428A NO970428A NO970428L NO 970428 L NO970428 L NO 970428L NO 970428 A NO970428 A NO 970428A NO 970428 A NO970428 A NO 970428A NO 970428 L NO970428 L NO 970428L
Authority
NO
Norway
Prior art keywords
compound
compounds
formula
lactam
unit
Prior art date
Application number
NO970428A
Other languages
English (en)
Other versions
NO970428D0 (no
Inventor
Jared Lynn Randall
Jane Ellen Godlewski
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO970428D0 publication Critical patent/NO970428D0/no
Publication of NO970428L publication Critical patent/NO970428L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/02—Preparation
    • C07D463/04—Preparation by forming the ring or condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen tilveiebringer fremgangsmåter for fremstilling av forbindelser med strukturen (Q-L^)-L-(L^-B) , hvor (1) Q er en kinolonenhet, (II) B er en laktamenhet, og (III) L, L^ og 1? utgjør sammen en bindingsenhet, og som omfatter trinnene med: (1) kobling av en forbindelse med formel (III) med en laktam- irmeholdende forbindelse til å danne en mellomproduktforbin- delse, og (2) ringslutning av mellomproduktet ved reaksjon med en organosilisiumforbindelse til å gi en forbindelse med formel (Q-L^)-L-(L^-B). Fremgangsmåten omfatter i tillegg ytterligere et trinn for koblingstrinnet, hvor beslcyttede former av forbindelsen med formel (III) og laktamforbindelsen dannes, og avbeskyttelsestrinn etter ringdannelsestrinnet, hvor beskyttelsesgruppene fjernes. Foretrulcne antimikrobielle forbindelser som fremstilles ved disse fremgangsmåter er dem hvor p-laktamenheten er penem, karbapenem, cefem eller karba- cefem. De forbindelser hvor L^, L og L^ danner en karbamat- enhet, eller en sekundær eller tertiær aminenhet er også foretrukne. Oppfirmelsen tilveiebringer også nys m.ellomproduktforbindclser med 0 Q R? formel (M-L^)-L-(L^-B) hvor (I) M har en struktur ifølge formel (IV) , (II) B ¿. ,. ^. er en laktamenhet, og (III) L, L og L utgjør sammen en bindingsenhet.
NO970428A 1994-08-02 1997-01-31 Fremgangsmåte for fremstilling av antimikrobielle kinolonyllaktamforbindelser og nye mellomprodukter NO970428L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28477194A 1994-08-02 1994-08-02
PCT/US1995/009649 WO1996004286A1 (en) 1994-08-02 1995-08-01 Process for making quinolonyl lactam antimicrobials and novel intermediate compounds

Publications (2)

Publication Number Publication Date
NO970428D0 NO970428D0 (no) 1997-01-31
NO970428L true NO970428L (no) 1997-04-02

Family

ID=23091468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970428A NO970428L (no) 1994-08-02 1997-01-31 Fremgangsmåte for fremstilling av antimikrobielle kinolonyllaktamforbindelser og nye mellomprodukter

Country Status (13)

Country Link
US (1) US5801242A (no)
EP (1) EP0775145A1 (no)
JP (1) JPH10503521A (no)
KR (1) KR100239200B1 (no)
CN (1) CN1159809A (no)
AU (1) AU3154095A (no)
BR (1) BR9508513A (no)
CA (1) CA2196539C (no)
FI (1) FI970426A7 (no)
MX (1) MX9700872A (no)
NO (1) NO970428L (no)
NZ (1) NZ290722A (no)
WO (1) WO1996004286A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020443A (en) * 1996-02-08 2000-02-01 Advanced Polymer Technologies, Inc. Polymerization of low grade DCPD monomers using an olefin metathesis catalyst
EP1280808A1 (en) * 2000-05-02 2003-02-05 NewBiotics, Inc. Improved beta-lactam antibiotics
ATE300522T1 (de) * 2000-12-14 2005-08-15 Procter & Gamble Cyclisierungsverfahrensschritt bei der herstellung von chinolonen und naphthyridinen
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
AR096135A1 (es) 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE279886C (no) *
US4383946A (en) * 1980-03-27 1983-05-17 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
NL8005041A (nl) * 1980-09-05 1982-04-01 Gist Brocades Nv Werkwijze voor de bereiding van thioethers, alsmede gesilyleerde thiolen voor toepassing bij deze werkwijze.
US4546176A (en) * 1982-12-14 1985-10-08 Eisai Co., Ltd. 7-Carboxymethoxyphenylacetamido-3-cephem derivatives and antibacterial preparations containing the same
EP0181521A1 (en) * 1984-10-19 1986-05-21 Otsuka Pharmaceutical Co., Ltd. Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds
US4755513A (en) * 1985-01-30 1988-07-05 Otsuka Pharmaceutical Company, Limited Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds
DE3509769A1 (de) * 1985-03-19 1986-09-25 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von carbapenemzwischenprodukten
US4684648A (en) * 1985-05-10 1987-08-04 Otsuka Pharmaceutical Company Limited Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds and compositions thereof
DE3542644A1 (de) * 1985-12-03 1987-06-04 Hoechst Ag Verfahren zur herstellung von cefodizim
JPS62215591A (ja) * 1986-03-14 1987-09-22 Dainippon Pharmaceut Co Ltd ピリドベンズオキサジン誘導体の製造法およびその中間体
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams
ES2148135T3 (es) * 1988-10-24 2000-10-16 Norwich Eaton Pharma Nuevos esteres antimicrobianos de quinolonil lactamas.
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
ZA912279B (en) * 1990-04-09 1992-02-26 Hoffmann La Roche Carbapenem compounds
KR920004385A (ko) * 1990-08-09 1992-03-27 와꾸나가 기스께 신규 삼환화합물 또는 그의 염, 이의 제조방법 및 이를 함유하는 항균제
IT1248011B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Procedimento per la preparazione dell'acido 9-fluoro-10- (4-metil-1-piperazinil)-7-oxo-2,3-diidro-7h-pirido (1,2,3-de) (1,4)benzotiadin-6-carbossilico cloridrato.
EP0606336B1 (en) * 1991-10-01 1997-03-19 PROCTER & GAMBLE PHARMACEUTICALS, INC. Process for making antimicrobial quinolonyl lactams
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones

Also Published As

Publication number Publication date
FI970426A7 (fi) 1997-03-25
EP0775145A1 (en) 1997-05-28
BR9508513A (pt) 1998-06-02
JPH10503521A (ja) 1998-03-31
FI970426A0 (fi) 1997-01-31
CA2196539A1 (en) 1996-02-15
MX9700872A (es) 1997-05-31
WO1996004286A1 (en) 1996-02-15
NO970428D0 (no) 1997-01-31
KR100239200B1 (ko) 2000-03-02
CA2196539C (en) 2001-05-15
NZ290722A (en) 1999-03-29
US5801242A (en) 1998-09-01
AU3154095A (en) 1996-03-04
CN1159809A (zh) 1997-09-17

Similar Documents

Publication Publication Date Title
EP0126587B1 (en) Carboxylic thio-pyrrolidinyl beta-lactam compounds and production thereof
CA2214793A1 (en) Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
ATE150463T1 (de) Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen
PT81226A (de) Verfahren zur herstellung von optisch aktiven acyloxazetidinonen
Ito et al. Highly stereocontrolled synthesis of the 1β-methylcarbapenem key intermediate by the reformatsky reaction of 3-(2-bromopropionyl)-2-oxazolidone derivatives with a 4-acetoxy-2-azetidinone
BG106728A (en) Chemical methods and intermediate compounds
NO970428L (no) Fremgangsmåte for fremstilling av antimikrobielle kinolonyllaktamforbindelser og nye mellomprodukter
DK0595111T4 (da) Carbazolonderivater og fremgangsmåde til deres fremstilling
AU1198897A (en) 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists
AU593874B2 (en) 2-heterocyclylthio penems
AU5778996A (en) Processes for preparing cyclic compounds
Bongini et al. Stereochemical Aspects of a Two‐Step Staudinger Reaction− Asymmetric Synthesis of Chiral Azetidine‐2‐ones
NO992058L (no) FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler
US4690922A (en) 2-(heterocycloalkylthio)penems
JPS62252786A (ja) ４−置換β−ラクタム化合物
CA1212112A (en) 4-cyano-2-azetidinones and production thereof
EP0109044B1 (en) Penems, pharmaceutical compositions containing them, process for preparing them
EP0121502B1 (en) Novel penem compounds, pharmaceutical compositions containing them, processes for their preparation
CA2264806A1 (en) Novel .beta.-lactam compounds and process for preparing the same
EP0260042B1 (en) 2-(1-oxo-1-imino-1-thiacycloalkyl)-thiopenem derivatives
US4540579A (en) 2-[(R) Amino acid alkyl]penems
US6080854A (en) Process for synthesizing carbapenem intermediates
EP0675127A4 (en) CHINOLINE CARBONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
AU1683500A (en) Hydronaphtho(2,3-C)furan derivatives and process for the preparation thereof
RU95105338A (ru) Трициклические цефемсульфоны, способ их получения, композиция

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application